nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—Lenalidomide—hematologic cancer	0.131	0.209	CbGbCtD
Salicylate-sodium—PTGS2—Thalidomide—hematologic cancer	0.0699	0.111	CbGbCtD
Salicylate-sodium—PTGS1—Bortezomib—hematologic cancer	0.0678	0.108	CbGbCtD
Salicylate-sodium—PTGS1—Thalidomide—hematologic cancer	0.0591	0.0941	CbGbCtD
Salicylate-sodium—PTGS1—Ifosfamide—hematologic cancer	0.052	0.0828	CbGbCtD
Salicylate-sodium—PTGS1—Imatinib—hematologic cancer	0.0497	0.0791	CbGbCtD
Salicylate-sodium—PTGS2—Triamcinolone—hematologic cancer	0.0485	0.0772	CbGbCtD
Salicylate-sodium—PTGS2—Betamethasone—hematologic cancer	0.0416	0.0662	CbGbCtD
Salicylate-sodium—PTGS2—Cisplatin—hematologic cancer	0.0299	0.0477	CbGbCtD
Salicylate-sodium—PTGS2—Etoposide—hematologic cancer	0.0294	0.0469	CbGbCtD
Salicylate-sodium—PTGS1—Etoposide—hematologic cancer	0.0248	0.0396	CbGbCtD
Salicylate-sodium—PTGS2—Dexamethasone—hematologic cancer	0.0242	0.0385	CbGbCtD
Salicylate-sodium—PTGS2—ovarian follicle—hematologic cancer	0.00692	0.556	CbGeAlD
Salicylate-sodium—Acetylsalicylic acid—HSPA5—hematologic cancer	0.00174	0.299	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—NFKBIA—hematologic cancer	0.00162	0.278	CrCbGaD
Salicylate-sodium—PTGS1—hematopoietic system—hematologic cancer	0.000874	0.0702	CbGeAlD
Salicylate-sodium—PTGS2—hematopoietic system—hematologic cancer	0.000835	0.0671	CbGeAlD
Salicylate-sodium—Acetylsalicylic acid—TP53—hematologic cancer	0.000716	0.123	CrCbGaD
Salicylate-sodium—Mesalazine—ALOX5—hematologic cancer	0.000674	0.116	CrCbGaD
Salicylate-sodium—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000669	0.209	CbGdCrCtD
Salicylate-sodium—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000669	0.209	CbGdCrCtD
Salicylate-sodium—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000654	0.205	CbGdCrCtD
Salicylate-sodium—PTGS1—blood—hematologic cancer	0.000579	0.0465	CbGeAlD
Salicylate-sodium—PTGS2—blood—hematologic cancer	0.000554	0.0445	CbGeAlD
Salicylate-sodium—PTGS2—bone marrow—hematologic cancer	0.000536	0.043	CbGeAlD
Salicylate-sodium—PTGS1—lung—hematologic cancer	0.000508	0.0408	CbGeAlD
Salicylate-sodium—PTGS2—lung—hematologic cancer	0.000485	0.039	CbGeAlD
Salicylate-sodium—PTGS1—testis—hematologic cancer	0.000479	0.0385	CbGeAlD
Salicylate-sodium—Mesalazine—MPO—hematologic cancer	0.000434	0.0745	CrCbGaD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000404	0.126	CbGdCrCtD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000404	0.126	CbGdCrCtD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000395	0.124	CbGdCrCtD
Salicylate-sodium—PTGS1—lymph node—hematologic cancer	0.000347	0.0279	CbGeAlD
Salicylate-sodium—PTGS2—lymph node—hematologic cancer	0.000332	0.0267	CbGeAlD
Salicylate-sodium—Magnesium salicylate—ALB—hematologic cancer	0.000196	0.0337	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—ALB—hematologic cancer	0.000125	0.0214	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—ABCB1—hematologic cancer	0.000119	0.0205	CrCbGaD
Salicylate-sodium—Salicylic acid—ALB—hematologic cancer	0.000103	0.0176	CrCbGaD
Salicylate-sodium—Salicylic acid—ABCB1—hematologic cancer	9.81e-05	0.0168	CrCbGaD
Salicylate-sodium—PTGS2—Disease—PSIP1—hematologic cancer	4.43e-05	0.000674	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PC—hematologic cancer	4.43e-05	0.000674	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—hematologic cancer	4.41e-05	0.000671	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	4.35e-05	0.000661	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—hematologic cancer	4.34e-05	0.00066	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	4.34e-05	0.000659	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SLC35B2—hematologic cancer	4.28e-05	0.000651	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HDAC10—hematologic cancer	4.28e-05	0.000651	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	4.24e-05	0.000645	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	4.23e-05	0.000642	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HDC—hematologic cancer	4.22e-05	0.000641	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTAP—hematologic cancer	4.13e-05	0.000628	CbGpPWpGaD
Salicylate-sodium—Pain—Triamcinolone—hematologic cancer	4.05e-05	0.000142	CcSEcCtD
Salicylate-sodium—Headache—Vincristine—hematologic cancer	4.04e-05	0.000142	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Prednisone—hematologic cancer	4.04e-05	0.000142	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	4.03e-05	0.000613	CbGpPWpGaD
Salicylate-sodium—Hypotension—Dexamethasone—hematologic cancer	4.02e-05	0.000141	CcSEcCtD
Salicylate-sodium—Hypotension—Betamethasone—hematologic cancer	4.02e-05	0.000141	CcSEcCtD
Salicylate-sodium—Nausea—Carmustine—hematologic cancer	4.02e-05	0.000141	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—hematologic cancer	4.01e-05	0.000141	CcSEcCtD
Salicylate-sodium—Vomiting—Mitoxantrone—hematologic cancer	4e-05	0.00014	CcSEcCtD
Salicylate-sodium—Vomiting—Irinotecan—hematologic cancer	4e-05	0.00014	CcSEcCtD
Salicylate-sodium—Nausea—Alitretinoin—hematologic cancer	3.98e-05	0.00014	CcSEcCtD
Salicylate-sodium—Convulsion—Prednisone—hematologic cancer	3.98e-05	0.00014	CcSEcCtD
Salicylate-sodium—Rash—Irinotecan—hematologic cancer	3.96e-05	0.000139	CcSEcCtD
Salicylate-sodium—Rash—Mitoxantrone—hematologic cancer	3.96e-05	0.000139	CcSEcCtD
Salicylate-sodium—Dermatitis—Irinotecan—hematologic cancer	3.96e-05	0.000139	CcSEcCtD
Salicylate-sodium—Dermatitis—Mitoxantrone—hematologic cancer	3.96e-05	0.000139	CcSEcCtD
Salicylate-sodium—Headache—Irinotecan—hematologic cancer	3.94e-05	0.000138	CcSEcCtD
Salicylate-sodium—Headache—Mitoxantrone—hematologic cancer	3.94e-05	0.000138	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	3.93e-05	0.000598	CbGpPWpGaD
Salicylate-sodium—Nausea—Ifosfamide—hematologic cancer	3.93e-05	0.000138	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Triamcinolone—hematologic cancer	3.91e-05	0.000137	CcSEcCtD
Salicylate-sodium—Diarrhoea—Cisplatin—hematologic cancer	3.9e-05	0.000137	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Epirubicin—hematologic cancer	3.9e-05	0.000137	CcSEcCtD
Salicylate-sodium—Anxiety—Prednisone—hematologic cancer	3.9e-05	0.000137	CcSEcCtD
Salicylate-sodium—Vomiting—Gemcitabine—hematologic cancer	3.89e-05	0.000137	CcSEcCtD
Salicylate-sodium—Paraesthesia—Dexamethasone—hematologic cancer	3.86e-05	0.000136	CcSEcCtD
Salicylate-sodium—Paraesthesia—Betamethasone—hematologic cancer	3.86e-05	0.000136	CcSEcCtD
Salicylate-sodium—Rash—Gemcitabine—hematologic cancer	3.86e-05	0.000135	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—CDA—hematologic cancer	3.86e-05	0.000586	CbGpPWpGaD
Salicylate-sodium—Dermatitis—Gemcitabine—hematologic cancer	3.86e-05	0.000135	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Etoposide—hematologic cancer	3.85e-05	0.000135	CcSEcCtD
Salicylate-sodium—Tinnitus—Epirubicin—hematologic cancer	3.85e-05	0.000135	CcSEcCtD
Salicylate-sodium—Erythema—Methotrexate—hematologic cancer	3.84e-05	0.000135	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.84e-05	0.000583	CbGpPWpGaD
Salicylate-sodium—Headache—Gemcitabine—hematologic cancer	3.84e-05	0.000135	CcSEcCtD
Salicylate-sodium—Nausea—Vincristine—hematologic cancer	3.83e-05	0.000135	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—hematologic cancer	3.82e-05	0.000134	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—HRAS—hematologic cancer	3.8e-05	0.000578	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Prednisolone—hematologic cancer	3.8e-05	0.000133	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—hematologic cancer	3.8e-05	0.000133	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MAPK3—hematologic cancer	3.79e-05	0.000576	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Betamethasone—hematologic cancer	3.79e-05	0.000133	CcSEcCtD
Salicylate-sodium—Dyspepsia—Dexamethasone—hematologic cancer	3.79e-05	0.000133	CcSEcCtD
Salicylate-sodium—Urticaria—Triamcinolone—hematologic cancer	3.77e-05	0.000132	CcSEcCtD
Salicylate-sodium—Dysgeusia—Methotrexate—hematologic cancer	3.76e-05	0.000132	CcSEcCtD
Salicylate-sodium—Asthenia—Etoposide—hematologic cancer	3.75e-05	0.000132	CcSEcCtD
Salicylate-sodium—Body temperature increased—Triamcinolone—hematologic cancer	3.75e-05	0.000132	CcSEcCtD
Salicylate-sodium—Oedema—Prednisone—hematologic cancer	3.75e-05	0.000131	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Prednisone—hematologic cancer	3.75e-05	0.000131	CcSEcCtD
Salicylate-sodium—Decreased appetite—Dexamethasone—hematologic cancer	3.74e-05	0.000131	CcSEcCtD
Salicylate-sodium—Decreased appetite—Betamethasone—hematologic cancer	3.74e-05	0.000131	CcSEcCtD
Salicylate-sodium—Nausea—Mitoxantrone—hematologic cancer	3.73e-05	0.000131	CcSEcCtD
Salicylate-sodium—Nausea—Irinotecan—hematologic cancer	3.73e-05	0.000131	CcSEcCtD
Salicylate-sodium—Infection—Prednisone—hematologic cancer	3.72e-05	0.000131	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—PC—hematologic cancer	3.71e-05	0.000564	CbGpPWpGaD
Salicylate-sodium—Fatigue—Dexamethasone—hematologic cancer	3.71e-05	0.00013	CcSEcCtD
Salicylate-sodium—Fatigue—Betamethasone—hematologic cancer	3.71e-05	0.00013	CcSEcCtD
Salicylate-sodium—Pruritus—Etoposide—hematologic cancer	3.7e-05	0.00013	CcSEcCtD
Salicylate-sodium—Shock—Prednisone—hematologic cancer	3.69e-05	0.000129	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MYC—hematologic cancer	3.69e-05	0.00056	CbGpPWpGaD
Salicylate-sodium—Arrhythmia—Epirubicin—hematologic cancer	3.68e-05	0.000129	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—FHL2—hematologic cancer	3.68e-05	0.00056	CbGpPWpGaD
Salicylate-sodium—Pain—Betamethasone—hematologic cancer	3.68e-05	0.000129	CcSEcCtD
Salicylate-sodium—Pain—Dexamethasone—hematologic cancer	3.68e-05	0.000129	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TGFB1—hematologic cancer	3.68e-05	0.000559	CbGpPWpGaD
Salicylate-sodium—Tachycardia—Prednisone—hematologic cancer	3.66e-05	0.000128	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	3.64e-05	0.000554	CbGpPWpGaD
Salicylate-sodium—Nausea—Gemcitabine—hematologic cancer	3.64e-05	0.000128	CcSEcCtD
Salicylate-sodium—Vomiting—Cisplatin—hematologic cancer	3.63e-05	0.000127	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Prednisone—hematologic cancer	3.62e-05	0.000127	CcSEcCtD
Salicylate-sodium—Vision blurred—Methotrexate—hematologic cancer	3.62e-05	0.000127	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—AGRN—hematologic cancer	3.61e-05	0.000549	CbGpPWpGaD
Salicylate-sodium—Erythema multiforme—Doxorubicin—hematologic cancer	3.61e-05	0.000127	CcSEcCtD
Salicylate-sodium—Rash—Cisplatin—hematologic cancer	3.6e-05	0.000126	CcSEcCtD
Salicylate-sodium—Dermatitis—Cisplatin—hematologic cancer	3.59e-05	0.000126	CcSEcCtD
Salicylate-sodium—Erythema—Epirubicin—hematologic cancer	3.59e-05	0.000126	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	3.59e-05	0.000546	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC35B2—hematologic cancer	3.59e-05	0.000545	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GBA—hematologic cancer	3.59e-05	0.000545	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Etoposide—hematologic cancer	3.58e-05	0.000126	CcSEcCtD
Salicylate-sodium—Anorexia—Prednisone—hematologic cancer	3.57e-05	0.000125	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—hematologic cancer	3.56e-05	0.000125	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Betamethasone—hematologic cancer	3.55e-05	0.000124	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dexamethasone—hematologic cancer	3.55e-05	0.000124	CcSEcCtD
Salicylate-sodium—Flatulence—Epirubicin—hematologic cancer	3.54e-05	0.000124	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Betamethasone—hematologic cancer	3.52e-05	0.000123	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.52e-05	0.000123	CcSEcCtD
Salicylate-sodium—Dysgeusia—Epirubicin—hematologic cancer	3.52e-05	0.000123	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—hematologic cancer	3.5e-05	0.000533	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Triamcinolone—hematologic cancer	3.49e-05	0.000123	CcSEcCtD
Salicylate-sodium—Dizziness—Etoposide—hematologic cancer	3.46e-05	0.000121	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—hematologic cancer	3.43e-05	0.000522	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HMMR—hematologic cancer	3.42e-05	0.00052	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—IDH2—hematologic cancer	3.42e-05	0.00052	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SNCA—hematologic cancer	3.42e-05	0.00052	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPLP1—hematologic cancer	3.42e-05	0.00052	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AGRN—hematologic cancer	3.42e-05	0.00052	CbGpPWpGaD
Salicylate-sodium—Urticaria—Betamethasone—hematologic cancer	3.42e-05	0.00012	CcSEcCtD
Salicylate-sodium—Urticaria—Dexamethasone—hematologic cancer	3.42e-05	0.00012	CcSEcCtD
Salicylate-sodium—Dizziness—Prednisolone—hematologic cancer	3.41e-05	0.00012	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—hematologic cancer	3.41e-05	0.00012	CcSEcCtD
Salicylate-sodium—Asthenia—Triamcinolone—hematologic cancer	3.4e-05	0.000119	CcSEcCtD
Salicylate-sodium—Body temperature increased—Betamethasone—hematologic cancer	3.4e-05	0.000119	CcSEcCtD
Salicylate-sodium—Abdominal pain—Betamethasone—hematologic cancer	3.4e-05	0.000119	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dexamethasone—hematologic cancer	3.4e-05	0.000119	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dexamethasone—hematologic cancer	3.4e-05	0.000119	CcSEcCtD
Salicylate-sodium—Nausea—Cisplatin—hematologic cancer	3.39e-05	0.000119	CcSEcCtD
Salicylate-sodium—Vision blurred—Epirubicin—hematologic cancer	3.38e-05	0.000119	CcSEcCtD
Salicylate-sodium—Paraesthesia—Prednisone—hematologic cancer	3.36e-05	0.000118	CcSEcCtD
Salicylate-sodium—Pruritus—Triamcinolone—hematologic cancer	3.35e-05	0.000118	CcSEcCtD
Salicylate-sodium—Convulsion—Methotrexate—hematologic cancer	3.32e-05	0.000117	CcSEcCtD
Salicylate-sodium—Vomiting—Etoposide—hematologic cancer	3.32e-05	0.000117	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—hematologic cancer	3.32e-05	0.000117	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—LEF1—hematologic cancer	3.3e-05	0.000502	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Prednisone—hematologic cancer	3.3e-05	0.000116	CcSEcCtD
Salicylate-sodium—Rash—Etoposide—hematologic cancer	3.3e-05	0.000116	CcSEcCtD
Salicylate-sodium—Dermatitis—Etoposide—hematologic cancer	3.29e-05	0.000116	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—MTAP—hematologic cancer	3.28e-05	0.000499	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	3.28e-05	0.000498	CbGpPWpGaD
Salicylate-sodium—Headache—Etoposide—hematologic cancer	3.28e-05	0.000115	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—hematologic cancer	3.27e-05	0.000115	CcSEcCtD
Salicylate-sodium—Chest pain—Methotrexate—hematologic cancer	3.27e-05	0.000115	CcSEcCtD
Salicylate-sodium—Decreased appetite—Prednisone—hematologic cancer	3.26e-05	0.000114	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—hematologic cancer	3.25e-05	0.000114	CcSEcCtD
Salicylate-sodium—Rash—Prednisolone—hematologic cancer	3.25e-05	0.000114	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisolone—hematologic cancer	3.25e-05	0.000114	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—HMMR—hematologic cancer	3.25e-05	0.000493	CbGpPWpGaD
Salicylate-sodium—Fatigue—Prednisone—hematologic cancer	3.23e-05	0.000113	CcSEcCtD
Salicylate-sodium—Headache—Prednisolone—hematologic cancer	3.23e-05	0.000113	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.23e-05	0.000491	CbGpPWpGaD
Salicylate-sodium—Syncope—Epirubicin—hematologic cancer	3.22e-05	0.000113	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ARNTL—hematologic cancer	3.22e-05	0.000489	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	3.21e-05	0.000488	CbGpPWpGaD
Salicylate-sodium—Constipation—Prednisone—hematologic cancer	3.2e-05	0.000112	CcSEcCtD
Salicylate-sodium—Palpitations—Epirubicin—hematologic cancer	3.17e-05	0.000111	CcSEcCtD
Salicylate-sodium—Confusional state—Methotrexate—hematologic cancer	3.16e-05	0.000111	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Epirubicin—hematologic cancer	3.16e-05	0.000111	CcSEcCtD
Salicylate-sodium—Dizziness—Triamcinolone—hematologic cancer	3.14e-05	0.00011	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Methotrexate—hematologic cancer	3.13e-05	0.00011	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ACP5—hematologic cancer	3.13e-05	0.000476	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA9—hematologic cancer	3.13e-05	0.000476	CbGpPWpGaD
Salicylate-sodium—Vision blurred—Doxorubicin—hematologic cancer	3.13e-05	0.00011	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	3.13e-05	0.000475	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	3.12e-05	0.000474	CbGpPWpGaD
Salicylate-sodium—Convulsion—Epirubicin—hematologic cancer	3.11e-05	0.000109	CcSEcCtD
Salicylate-sodium—Infection—Methotrexate—hematologic cancer	3.11e-05	0.000109	CcSEcCtD
Salicylate-sodium—Nausea—Etoposide—hematologic cancer	3.11e-05	0.000109	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—NCOR2—hematologic cancer	3.09e-05	0.00047	CbGpPWpGaD
Salicylate-sodium—Feeling abnormal—Prednisone—hematologic cancer	3.09e-05	0.000108	CcSEcCtD
Salicylate-sodium—Asthenia—Dexamethasone—hematologic cancer	3.09e-05	0.000108	CcSEcCtD
Salicylate-sodium—Asthenia—Betamethasone—hematologic cancer	3.09e-05	0.000108	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Prednisone—hematologic cancer	3.06e-05	0.000108	CcSEcCtD
Salicylate-sodium—Nausea—Prednisolone—hematologic cancer	3.06e-05	0.000107	CcSEcCtD
Salicylate-sodium—Chest pain—Epirubicin—hematologic cancer	3.06e-05	0.000107	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—ELL—hematologic cancer	3.05e-05	0.000464	CbGpPWpGaD
Salicylate-sodium—Anxiety—Epirubicin—hematologic cancer	3.05e-05	0.000107	CcSEcCtD
Salicylate-sodium—Pruritus—Betamethasone—hematologic cancer	3.04e-05	0.000107	CcSEcCtD
Salicylate-sodium—Pruritus—Dexamethasone—hematologic cancer	3.04e-05	0.000107	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Methotrexate—hematologic cancer	3.03e-05	0.000106	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TP53—hematologic cancer	3.03e-05	0.00046	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	3.02e-05	0.00046	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	3.02e-05	0.000459	CbGpPWpGaD
Salicylate-sodium—Vomiting—Triamcinolone—hematologic cancer	3.01e-05	0.000106	CcSEcCtD
Salicylate-sodium—Rash—Triamcinolone—hematologic cancer	2.99e-05	0.000105	CcSEcCtD
Salicylate-sodium—Dermatitis—Triamcinolone—hematologic cancer	2.99e-05	0.000105	CcSEcCtD
Salicylate-sodium—Anorexia—Methotrexate—hematologic cancer	2.98e-05	0.000105	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—hematologic cancer	2.98e-05	0.000105	CcSEcCtD
Salicylate-sodium—Urticaria—Prednisone—hematologic cancer	2.98e-05	0.000104	CcSEcCtD
Salicylate-sodium—Headache—Triamcinolone—hematologic cancer	2.97e-05	0.000104	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—ACP5—hematologic cancer	2.97e-05	0.000451	CbGpPWpGaD
Salicylate-sodium—Abdominal pain—Prednisone—hematologic cancer	2.96e-05	0.000104	CcSEcCtD
Salicylate-sodium—Body temperature increased—Prednisone—hematologic cancer	2.96e-05	0.000104	CcSEcCtD
Salicylate-sodium—Confusional state—Epirubicin—hematologic cancer	2.95e-05	0.000104	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.95e-05	0.000449	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—IDH1—hematologic cancer	2.94e-05	0.000448	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Dexamethasone—hematologic cancer	2.94e-05	0.000103	CcSEcCtD
Salicylate-sodium—Diarrhoea—Betamethasone—hematologic cancer	2.94e-05	0.000103	CcSEcCtD
Salicylate-sodium—Palpitations—Doxorubicin—hematologic cancer	2.94e-05	0.000103	CcSEcCtD
Salicylate-sodium—Oedema—Epirubicin—hematologic cancer	2.93e-05	0.000103	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Epirubicin—hematologic cancer	2.93e-05	0.000103	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—NCOR2—hematologic cancer	2.93e-05	0.000445	CbGpPWpGaD
Salicylate-sodium—Hypotension—Methotrexate—hematologic cancer	2.93e-05	0.000103	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—FHL2—hematologic cancer	2.92e-05	0.000444	CbGpPWpGaD
Salicylate-sodium—Loss of consciousness—Doxorubicin—hematologic cancer	2.92e-05	0.000102	CcSEcCtD
Salicylate-sodium—Infection—Epirubicin—hematologic cancer	2.91e-05	0.000102	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—GSTO1—hematologic cancer	2.91e-05	0.000443	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCC3—hematologic cancer	2.91e-05	0.000443	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TXN—hematologic cancer	2.91e-05	0.000443	CbGpPWpGaD
Salicylate-sodium—Shock—Epirubicin—hematologic cancer	2.88e-05	0.000101	CcSEcCtD
Salicylate-sodium—Convulsion—Doxorubicin—hematologic cancer	2.88e-05	0.000101	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.88e-05	0.000437	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AGRN—hematologic cancer	2.87e-05	0.000436	CbGpPWpGaD
Salicylate-sodium—Tachycardia—Epirubicin—hematologic cancer	2.86e-05	0.0001	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—SPHK1—hematologic cancer	2.85e-05	0.000433	CbGpPWpGaD
Salicylate-sodium—Dizziness—Dexamethasone—hematologic cancer	2.85e-05	9.98e-05	CcSEcCtD
Salicylate-sodium—Dizziness—Betamethasone—hematologic cancer	2.85e-05	9.98e-05	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Epirubicin—hematologic cancer	2.83e-05	9.94e-05	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—hematologic cancer	2.83e-05	9.93e-05	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—hematologic cancer	2.82e-05	9.89e-05	CcSEcCtD
Salicylate-sodium—Nausea—Triamcinolone—hematologic cancer	2.82e-05	9.88e-05	CcSEcCtD
Salicylate-sodium—Paraesthesia—Methotrexate—hematologic cancer	2.81e-05	9.87e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.8e-05	0.000425	CbGpPWpGaD
Salicylate-sodium—Anorexia—Epirubicin—hematologic cancer	2.79e-05	9.8e-05	CcSEcCtD
Salicylate-sodium—Dyspnoea—Methotrexate—hematologic cancer	2.79e-05	9.8e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—IDH1—hematologic cancer	2.79e-05	0.000424	CbGpPWpGaD
Salicylate-sodium—Somnolence—Methotrexate—hematologic cancer	2.78e-05	9.77e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	2.77e-05	0.000421	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Prednisone—hematologic cancer	2.76e-05	9.69e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—GSTO1—hematologic cancer	2.76e-05	0.000419	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Methotrexate—hematologic cancer	2.76e-05	9.67e-05	CcSEcCtD
Salicylate-sodium—Hypotension—Epirubicin—hematologic cancer	2.74e-05	9.61e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—UGT1A1—hematologic cancer	2.74e-05	0.000416	CbGpPWpGaD
Salicylate-sodium—Vomiting—Betamethasone—hematologic cancer	2.74e-05	9.6e-05	CcSEcCtD
Salicylate-sodium—Vomiting—Dexamethasone—hematologic cancer	2.74e-05	9.6e-05	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—hematologic cancer	2.73e-05	9.59e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.73e-05	0.000414	CbGpPWpGaD
Salicylate-sodium—Decreased appetite—Methotrexate—hematologic cancer	2.72e-05	9.55e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—HMMR—hematologic cancer	2.72e-05	0.000413	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—IDH2—hematologic cancer	2.72e-05	0.000413	CbGpPWpGaD
Salicylate-sodium—Rash—Dexamethasone—hematologic cancer	2.71e-05	9.52e-05	CcSEcCtD
Salicylate-sodium—Rash—Betamethasone—hematologic cancer	2.71e-05	9.52e-05	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—hematologic cancer	2.71e-05	9.51e-05	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—hematologic cancer	2.71e-05	9.51e-05	CcSEcCtD
Salicylate-sodium—Dermatitis—Dexamethasone—hematologic cancer	2.71e-05	9.51e-05	CcSEcCtD
Salicylate-sodium—Dermatitis—Betamethasone—hematologic cancer	2.71e-05	9.51e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—AGO2—hematologic cancer	2.7e-05	0.000411	CbGpPWpGaD
Salicylate-sodium—Fatigue—Methotrexate—hematologic cancer	2.7e-05	9.47e-05	CcSEcCtD
Salicylate-sodium—Headache—Dexamethasone—hematologic cancer	2.7e-05	9.46e-05	CcSEcCtD
Salicylate-sodium—Headache—Betamethasone—hematologic cancer	2.7e-05	9.46e-05	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—hematologic cancer	2.69e-05	9.45e-05	CcSEcCtD
Salicylate-sodium—Asthenia—Prednisone—hematologic cancer	2.69e-05	9.43e-05	CcSEcCtD
Salicylate-sodium—Pain—Methotrexate—hematologic cancer	2.68e-05	9.4e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—HDAC9—hematologic cancer	2.67e-05	0.000406	CbGpPWpGaD
Salicylate-sodium—Shock—Doxorubicin—hematologic cancer	2.67e-05	9.36e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—CRABP1—hematologic cancer	2.66e-05	0.000405	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC22A1—hematologic cancer	2.66e-05	0.000405	CbGpPWpGaD
Salicylate-sodium—Pruritus—Prednisone—hematologic cancer	2.65e-05	9.3e-05	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—hematologic cancer	2.65e-05	9.29e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—H3F3B—hematologic cancer	2.65e-05	0.000402	CbGpPWpGaD
Salicylate-sodium—Paraesthesia—Epirubicin—hematologic cancer	2.63e-05	9.23e-05	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—hematologic cancer	2.62e-05	9.2e-05	CcSEcCtD
Salicylate-sodium—Dyspnoea—Epirubicin—hematologic cancer	2.61e-05	9.17e-05	CcSEcCtD
Salicylate-sodium—Somnolence—Epirubicin—hematologic cancer	2.61e-05	9.14e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ALOX5—hematologic cancer	2.59e-05	0.000394	CbGpPWpGaD
Salicylate-sodium—Anorexia—Doxorubicin—hematologic cancer	2.58e-05	9.07e-05	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Methotrexate—hematologic cancer	2.58e-05	9.05e-05	CcSEcCtD
Salicylate-sodium—Dyspepsia—Epirubicin—hematologic cancer	2.58e-05	9.05e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.58e-05	0.000392	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Prednisone—hematologic cancer	2.56e-05	9e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.56e-05	0.00039	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Methotrexate—hematologic cancer	2.56e-05	8.99e-05	CcSEcCtD
Salicylate-sodium—Nausea—Dexamethasone—hematologic cancer	2.56e-05	8.97e-05	CcSEcCtD
Salicylate-sodium—Nausea—Betamethasone—hematologic cancer	2.56e-05	8.97e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ARNTL—hematologic cancer	2.56e-05	0.000388	CbGpPWpGaD
Salicylate-sodium—Decreased appetite—Epirubicin—hematologic cancer	2.55e-05	8.94e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—NPM1—hematologic cancer	2.55e-05	0.000387	CbGpPWpGaD
Salicylate-sodium—Hypotension—Doxorubicin—hematologic cancer	2.53e-05	8.89e-05	CcSEcCtD
Salicylate-sodium—Fatigue—Epirubicin—hematologic cancer	2.53e-05	8.87e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—NUP98—hematologic cancer	2.51e-05	0.000382	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.51e-05	0.000381	CbGpPWpGaD
Salicylate-sodium—Pain—Epirubicin—hematologic cancer	2.51e-05	8.79e-05	CcSEcCtD
Salicylate-sodium—Constipation—Epirubicin—hematologic cancer	2.51e-05	8.79e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.5e-05	0.00038	CbGpPWpGaD
Salicylate-sodium—Urticaria—Methotrexate—hematologic cancer	2.49e-05	8.73e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ACP5—hematologic cancer	2.49e-05	0.000378	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA9—hematologic cancer	2.49e-05	0.000378	CbGpPWpGaD
Salicylate-sodium—Dizziness—Prednisone—hematologic cancer	2.48e-05	8.69e-05	CcSEcCtD
Salicylate-sodium—Abdominal pain—Methotrexate—hematologic cancer	2.48e-05	8.69e-05	CcSEcCtD
Salicylate-sodium—Body temperature increased—Methotrexate—hematologic cancer	2.48e-05	8.69e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—NCOR2—hematologic cancer	2.45e-05	0.000373	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADCY7—hematologic cancer	2.44e-05	0.000371	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NCOA3—hematologic cancer	2.44e-05	0.000371	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF19—hematologic cancer	2.44e-05	0.000371	CbGpPWpGaD
Salicylate-sodium—Paraesthesia—Doxorubicin—hematologic cancer	2.43e-05	8.54e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—NUP214—hematologic cancer	2.42e-05	0.000368	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPS14—hematologic cancer	2.42e-05	0.000368	CbGpPWpGaD
Salicylate-sodium—Dyspnoea—Doxorubicin—hematologic cancer	2.42e-05	8.48e-05	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Epirubicin—hematologic cancer	2.41e-05	8.47e-05	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—hematologic cancer	2.41e-05	8.46e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—DKK1—hematologic cancer	2.4e-05	0.000365	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.4e-05	0.000364	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Epirubicin—hematologic cancer	2.4e-05	8.41e-05	CcSEcCtD
Salicylate-sodium—Dyspepsia—Doxorubicin—hematologic cancer	2.39e-05	8.38e-05	CcSEcCtD
Salicylate-sodium—Vomiting—Prednisone—hematologic cancer	2.38e-05	8.36e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—NUP98—hematologic cancer	2.38e-05	0.000362	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT5B—hematologic cancer	2.38e-05	0.000362	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCG2—hematologic cancer	2.37e-05	0.000361	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTR—hematologic cancer	2.37e-05	0.000361	CbGpPWpGaD
Salicylate-sodium—Rash—Prednisone—hematologic cancer	2.36e-05	8.29e-05	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisone—hematologic cancer	2.36e-05	8.28e-05	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—hematologic cancer	2.36e-05	8.27e-05	CcSEcCtD
Salicylate-sodium—Headache—Prednisone—hematologic cancer	2.35e-05	8.24e-05	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—hematologic cancer	2.34e-05	8.2e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—IDH1—hematologic cancer	2.34e-05	0.000355	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.34e-05	0.000355	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CST3—hematologic cancer	2.33e-05	0.000354	CbGpPWpGaD
Salicylate-sodium—Urticaria—Epirubicin—hematologic cancer	2.33e-05	8.17e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ENO2—hematologic cancer	2.33e-05	0.000354	CbGpPWpGaD
Salicylate-sodium—Pain—Doxorubicin—hematologic cancer	2.32e-05	8.14e-05	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—hematologic cancer	2.32e-05	8.14e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.32e-05	0.000352	CbGpPWpGaD
Salicylate-sodium—Body temperature increased—Epirubicin—hematologic cancer	2.32e-05	8.13e-05	CcSEcCtD
Salicylate-sodium—Abdominal pain—Epirubicin—hematologic cancer	2.32e-05	8.13e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—ADCY7—hematologic cancer	2.31e-05	0.000352	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCC3—hematologic cancer	2.31e-05	0.000351	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTO1—hematologic cancer	2.31e-05	0.000351	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TXN—hematologic cancer	2.31e-05	0.000351	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Methotrexate—hematologic cancer	2.31e-05	8.1e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—NUP214—hematologic cancer	2.3e-05	0.000349	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SPHK1—hematologic cancer	2.26e-05	0.000344	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTT1—hematologic cancer	2.26e-05	0.000343	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—XIAP—hematologic cancer	2.25e-05	0.000342	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTR—hematologic cancer	2.25e-05	0.000342	CbGpPWpGaD
Salicylate-sodium—Asthenia—Methotrexate—hematologic cancer	2.25e-05	7.88e-05	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—hematologic cancer	2.23e-05	7.84e-05	CcSEcCtD
Salicylate-sodium—Nausea—Prednisone—hematologic cancer	2.23e-05	7.81e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.22e-05	0.000338	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.22e-05	7.78e-05	CcSEcCtD
Salicylate-sodium—Pruritus—Methotrexate—hematologic cancer	2.22e-05	7.77e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—SDC1—hematologic cancer	2.21e-05	0.000335	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ENO2—hematologic cancer	2.21e-05	0.000335	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SMARCA4—hematologic cancer	2.19e-05	0.000333	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—UGT1A1—hematologic cancer	2.17e-05	0.00033	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Epirubicin—hematologic cancer	2.16e-05	7.58e-05	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—hematologic cancer	2.15e-05	7.56e-05	CcSEcCtD
Salicylate-sodium—Abdominal pain—Doxorubicin—hematologic cancer	2.14e-05	7.52e-05	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—hematologic cancer	2.14e-05	7.52e-05	CcSEcCtD
Salicylate-sodium—Diarrhoea—Methotrexate—hematologic cancer	2.14e-05	7.52e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.13e-05	0.000324	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC22A1—hematologic cancer	2.11e-05	0.000321	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CRABP1—hematologic cancer	2.11e-05	0.000321	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.11e-05	0.00032	CbGpPWpGaD
Salicylate-sodium—Asthenia—Epirubicin—hematologic cancer	2.1e-05	7.38e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—SDC1—hematologic cancer	2.09e-05	0.000318	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.08e-05	0.000316	CbGpPWpGaD
Salicylate-sodium—Pruritus—Epirubicin—hematologic cancer	2.07e-05	7.28e-05	CcSEcCtD
Salicylate-sodium—Dizziness—Methotrexate—hematologic cancer	2.07e-05	7.27e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ALOX5—hematologic cancer	2.06e-05	0.000313	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.06e-05	0.000313	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LCK—hematologic cancer	2.03e-05	0.000308	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Epirubicin—hematologic cancer	2.01e-05	7.04e-05	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Doxorubicin—hematologic cancer	2e-05	7.01e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—NUP98—hematologic cancer	1.99e-05	0.000303	CbGpPWpGaD
Salicylate-sodium—Vomiting—Methotrexate—hematologic cancer	1.99e-05	6.99e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.99e-05	0.000303	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—H3F3A—hematologic cancer	1.99e-05	0.000302	CbGpPWpGaD
Salicylate-sodium—Rash—Methotrexate—hematologic cancer	1.97e-05	6.93e-05	CcSEcCtD
Salicylate-sodium—Dermatitis—Methotrexate—hematologic cancer	1.97e-05	6.92e-05	CcSEcCtD
Salicylate-sodium—Headache—Methotrexate—hematologic cancer	1.96e-05	6.88e-05	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—hematologic cancer	1.95e-05	6.83e-05	CcSEcCtD
Salicylate-sodium—Dizziness—Epirubicin—hematologic cancer	1.94e-05	6.8e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ADCY7—hematologic cancer	1.94e-05	0.000294	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NCOA3—hematologic cancer	1.94e-05	0.000294	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PRKCZ—hematologic cancer	1.93e-05	0.000293	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NUP214—hematologic cancer	1.92e-05	0.000292	CbGpPWpGaD
Salicylate-sodium—Pruritus—Doxorubicin—hematologic cancer	1.92e-05	6.73e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.9e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CALR—hematologic cancer	1.9e-05	0.000288	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTR—hematologic cancer	1.88e-05	0.000286	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCG2—hematologic cancer	1.88e-05	0.000286	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NQO1—hematologic cancer	1.88e-05	0.000285	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CD44—hematologic cancer	1.88e-05	0.000285	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PARP1—hematologic cancer	1.86e-05	0.000283	CbGpPWpGaD
Salicylate-sodium—Vomiting—Epirubicin—hematologic cancer	1.86e-05	6.54e-05	CcSEcCtD
Salicylate-sodium—Nausea—Methotrexate—hematologic cancer	1.86e-05	6.53e-05	CcSEcCtD
Salicylate-sodium—Diarrhoea—Doxorubicin—hematologic cancer	1.86e-05	6.51e-05	CcSEcCtD
Salicylate-sodium—Rash—Epirubicin—hematologic cancer	1.85e-05	6.48e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ENO2—hematologic cancer	1.85e-05	0.000281	CbGpPWpGaD
Salicylate-sodium—Dermatitis—Epirubicin—hematologic cancer	1.85e-05	6.48e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.84e-05	0.000279	CbGpPWpGaD
Salicylate-sodium—Headache—Epirubicin—hematologic cancer	1.84e-05	6.44e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—FBXW7—hematologic cancer	1.83e-05	0.000279	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HDAC2—hematologic cancer	1.8e-05	0.000273	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CXCR4—hematologic cancer	1.8e-05	0.000273	CbGpPWpGaD
Salicylate-sodium—Dizziness—Doxorubicin—hematologic cancer	1.79e-05	6.29e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—GSTT1—hematologic cancer	1.79e-05	0.000272	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD44—hematologic cancer	1.78e-05	0.00027	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYCS—hematologic cancer	1.77e-05	0.00027	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.76e-05	0.000268	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.76e-05	0.000268	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CBL—hematologic cancer	1.75e-05	0.000266	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SDC1—hematologic cancer	1.75e-05	0.000266	CbGpPWpGaD
Salicylate-sodium—Nausea—Epirubicin—hematologic cancer	1.74e-05	6.11e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.74e-05	0.000264	CbGpPWpGaD
Salicylate-sodium—Vomiting—Doxorubicin—hematologic cancer	1.72e-05	6.05e-05	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—hematologic cancer	1.71e-05	6e-05	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—hematologic cancer	1.71e-05	5.99e-05	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—hematologic cancer	1.7e-05	5.96e-05	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.67e-05	0.000254	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HSP90AA1—hematologic cancer	1.67e-05	0.000254	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.65e-05	0.000251	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT1—hematologic cancer	1.61e-05	0.000245	CbGpPWpGaD
Salicylate-sodium—Nausea—Doxorubicin—hematologic cancer	1.61e-05	5.65e-05	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.59e-05	0.000241	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.58e-05	0.00024	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTP1—hematologic cancer	1.56e-05	0.000238	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.51e-05	0.00023	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GRB2—hematologic cancer	1.51e-05	0.000229	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PDGFA—hematologic cancer	1.5e-05	0.000229	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NQO1—hematologic cancer	1.49e-05	0.000226	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CD44—hematologic cancer	1.49e-05	0.000226	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KITLG—hematologic cancer	1.48e-05	0.000225	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCB1—hematologic cancer	1.48e-05	0.000225	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.46e-05	0.000222	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT5A—hematologic cancer	1.45e-05	0.00022	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NCOR1—hematologic cancer	1.44e-05	0.000219	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM1—hematologic cancer	1.44e-05	0.000219	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN2B—hematologic cancer	1.44e-05	0.000218	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYCS—hematologic cancer	1.41e-05	0.000214	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.4e-05	0.000213	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD86—hematologic cancer	1.39e-05	0.000211	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HES1—hematologic cancer	1.37e-05	0.000208	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NCOR1—hematologic cancer	1.36e-05	0.000207	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF1—hematologic cancer	1.35e-05	0.000205	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FOXO1—hematologic cancer	1.33e-05	0.000202	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PDGFRB—hematologic cancer	1.33e-05	0.000202	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PDGFRA—hematologic cancer	1.31e-05	0.000198	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—JAK1—hematologic cancer	1.3e-05	0.000198	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PRKCG—hematologic cancer	1.3e-05	0.000198	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTHFR—hematologic cancer	1.27e-05	0.000193	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.26e-05	0.000192	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTP1—hematologic cancer	1.24e-05	0.000189	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTHFR—hematologic cancer	1.2e-05	0.000183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.2e-05	0.000183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HLA-A—hematologic cancer	1.2e-05	0.000183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TERT—hematologic cancer	1.2e-05	0.000183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCB1—hematologic cancer	1.18e-05	0.000179	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PDGFB—hematologic cancer	1.17e-05	0.000178	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TSC2—hematologic cancer	1.15e-05	0.000174	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM1—hematologic cancer	1.14e-05	0.000174	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NCOR1—hematologic cancer	1.14e-05	0.000174	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.12e-05	0.00017	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGFR3—hematologic cancer	1.1e-05	0.000168	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.07e-05	0.000162	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—BAD—hematologic cancer	1.04e-05	0.000159	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOTCH1—hematologic cancer	1.03e-05	0.000157	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD80—hematologic cancer	1.01e-05	0.000154	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KIT—hematologic cancer	1.01e-05	0.000154	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTHFR—hematologic cancer	1.01e-05	0.000153	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PTPN11—hematologic cancer	9.94e-06	0.000151	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CREBBP—hematologic cancer	9.9e-06	0.00015	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CREB1—hematologic cancer	9.63e-06	0.000146	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—BRAF—hematologic cancer	9.51e-06	0.000145	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6R—hematologic cancer	9.4e-06	0.000143	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CD—hematologic cancer	9.38e-06	0.000143	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CREBBP—hematologic cancer	9.38e-06	0.000143	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALB—hematologic cancer	9.26e-06	0.000141	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAP2K1—hematologic cancer	8.96e-06	0.000136	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CD—hematologic cancer	8.9e-06	0.000135	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.89e-06	0.000135	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3R1—hematologic cancer	8.86e-06	0.000135	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF2—hematologic cancer	8.52e-06	0.000129	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CG—hematologic cancer	8.47e-06	0.000129	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3R1—hematologic cancer	8.4e-06	0.000128	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CB—hematologic cancer	8.18e-06	0.000124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—JAK2—hematologic cancer	8.16e-06	0.000124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MDM2—hematologic cancer	7.97e-06	0.000121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CREBBP—hematologic cancer	7.86e-06	0.000119	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CB—hematologic cancer	7.75e-06	0.000118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTOR—hematologic cancer	7.75e-06	0.000118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD4—hematologic cancer	7.74e-06	0.000118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CD—hematologic cancer	7.45e-06	0.000113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALB—hematologic cancer	7.35e-06	0.000112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1B—hematologic cancer	7.28e-06	0.000111	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTEN—hematologic cancer	7.07e-06	0.000107	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3R1—hematologic cancer	7.04e-06	0.000107	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—EP300—hematologic cancer	6.74e-06	0.000102	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1A—hematologic cancer	6.72e-06	0.000102	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PTEN—hematologic cancer	6.7e-06	0.000102	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CB—hematologic cancer	6.49e-06	9.87e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EP300—hematologic cancer	6.39e-06	9.71e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SRC—hematologic cancer	6.21e-06	9.45e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT3—hematologic cancer	5.99e-06	9.11e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NRAS—hematologic cancer	5.98e-06	9.09e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAPK3—hematologic cancer	5.73e-06	8.7e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PTEN—hematologic cancer	5.61e-06	8.53e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MYC—hematologic cancer	5.57e-06	8.47e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TGFB1—hematologic cancer	5.55e-06	8.44e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—EP300—hematologic cancer	5.35e-06	8.14e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KRAS—hematologic cancer	5.15e-06	7.82e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CA—hematologic cancer	4.99e-06	7.58e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CA—hematologic cancer	4.73e-06	7.19e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HRAS—hematologic cancer	4.37e-06	6.65e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—hematologic cancer	4.19e-06	6.36e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKT1—hematologic cancer	4.07e-06	6.19e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CA—hematologic cancer	3.96e-06	6.02e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT1—hematologic cancer	3.86e-06	5.87e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKT1—hematologic cancer	3.23e-06	4.92e-05	CbGpPWpGaD
